Stepwise analysis of thyroid diagnostic modalities with genomic imprinting detection
Authors:
Open Access
- 1 April 2024
- journal article
- research article
- Published by AME Publishing Company in Chinese Clinical Oncology
- Vol. 13 (2) , 21
Abstract
Background: The current preoperative malignancy risk evaluation for thyroid nodules involves stepwise diagnostic modalities including ultrasonography, thyroid function serology and fine-needle aspiration (FNA) cytopathology, respectively. We aimed to substantiate the stepwise contributions of each diagnostic step and additionally investigate the diagnostic significance of quantitative chromogenic imprinted gene in-situ hybridization (QCIGISH)—an adjunctive molecular test based on epigenetic imprinting alterations. Methods: A total of 114 cytopathologically-diagnosed and histopathologically-confirmed thyroid nodules with complete ultrasonographic and serological examination records were evaluated using QCIGISH in the study. Logistic regression models for thyroid malignancy prediction were developed with the stepwise addition of each diagnostic modality and the contribution of each step evaluated in terms of discrimination performance and goodness-of-fit. Results: From the baseline model using ultrasonography [area under the receiver operating characteristics curve (AUROC): 0.79; 95% confidence interval (CI): 0.71–0.86], significant improvements in thyroid malignancy discrimination were observed with the stepwise addition of thyroid function serology (AUROC: 0.82; 95% CI: 0.74–0.90; P=0.23) and FNA cytopathology (AUROC: 0.88; 95% CI: 0.81–0.94; P=0.02), respectively. The inclusion of QCIGISH as an adjunctive molecular test further advanced the preceding model’s diagnostic performance (AUROC: 0.95; 95% CI: 0.91–1.00, P=0.007). Conclusions: Our study demonstrated the significant stepwise diagnostic contributions of standard clinical assessments in the malignancy risk stratification of thyroid nodules. However, the addition of molecular imprinting detection further enabled a more accurate and definitive preoperative evaluation especially for morphologically indeterminate thyroid nodules and cases with potentially discordant results among standard modalities.Keywords
This publication has 49 references indexed in Scilit:
- Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid NodulesJAMA Network Open, 2023
- Fasting serum glucose, thyroid‐stimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: A case‐control studyHead & Neck, 2019
- Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate CytologyJAMA Oncology, 2019
- Applied Statistics for Human Genetics Using R2018
- The Diagnosis and Management of Thyroid NodulesJAMA, 2018
- Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodulesCancer, 2018
- Molecular testing for thyroid nodules: Review and current stateCancer, 2017
- Hobnail Variant of Papillary Thyroid Carcinoma: a Literature ReviewEndocrine Pathology, 2017
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid CancerJAMA, 2013
- American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive Summary of recommendationsJournal of Endocrinological Investigation, 2010